Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative esmolol infusion for hemodynamic stability during major vascular surgery
NL-OMON20345Phase 4Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Mar 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esmolol and metoprolol in coronary arteriosclerosis, arteriosclerosis obliterans, carotid atheroma (CAS) and 1 more (2 arms), sponsored by Erasmus MC. Primary endpoint: Hemodynamic stability during first 24 hours. Started Mar 2011; status: active, not recruiting.
02
Drugs
esmololmetoprolol
03
Conditions
coronary arteriosclerosisarteriosclerosis obliteranscarotid atheroma (CAS)abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NL-OMON20345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20345.